Tuesday, October 20, 2009

Translational Studies in Anterior Cruciate Ligament Repair

http://www.liebertonline.com/doi/abs/10.1089/ten.tea.2009.0147

  • WHY NEED IT-"Recent years have shown a clearer
    definition of the clinical problem and established an underlying mechanistic cause of the incapacity of the
    anterior cruciate ligament to heal—the premature loss of provisional scaffold in the wound site. These clinical
    findings were then translated into a research objective, namely, to replace the missing scaffold with a biomaterial
    with appropriate structural and bio-stimulatory characteristics."
  • WHY NEED IT- "Current estimates of
    the prevalence of reported ACL tears range at 4.8% of ambulatory
    individuals between 50 and 90 years of age, but it is
    very likely that the actual number, including asymptomatic
    tears in patients with low demand, is even higher.2,3 The risk
    of ACL tears is significantly increased by participating in
    particular sports, especially those involving pivoting, and for
    women.4–8 ACL tears are serious injuries causing immediate
    pain and loss of mobility."
  • COLLAGEN AS BIOMATERIAL- "Among all biomaterials currently used in tissue
    engineering, collagen has a long-standing record as a biocompatible,
    biodegradable, and safe material for orthopedic
    applications and is the main constituent of the ACL"
  • COLLAGEN IN COW ACL- "Murray et al. showed that cells from human torn ACL
    migrate into a scaffold made from bovine atelocollagen (Fig. 3) and secrete smooth muscle actin, which causes
    wound contraction44,45,62 (Fig. 2). ACL fibroblasts retain this
    ability also in the ruptured ACL, where they exhibit even
    higher outgrowth rates.62"
  • WHY DOES ACL NOT HEAL- "A translational research approach helped to identify one
    potential reason why the torn ACL does not heal: the lack of a fibrin clot that stabilizes the defect and serves as a scaffold
    for cell migration and a source for stimulating factors."

No comments:

Post a Comment